RxDoctor Payments Data

Shima Lavigno

Medical · Suwanee, GANPI 1679855001

Payments from drug & device makers

$1,821in general payments, 2019–2025

Across 87 payments — averaging $20.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$237
  • AstraZeneca$227
  • Astellas Pharma US Inc$180
  • Lilly USA, LLC$172
  • AbbVie$158
  • Bayer$117
  • plus $730 from 23 others

What the payments were for

  • Food & beverage$1,821100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,821 in reported general payments places this provider in the 65th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide14$16,381
Bupropion XlBupropion Hcl13$629
Losartan Potassium52$590
Ezetimibe19$567
Rosuvastatin Calcium68$563
Levothyroxine Sodium61$456
Atorvastatin Calcium64$441
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide20$393
Albuterol Sulfate HfaAlbuterol Sulfate15$385
Escitalopram Oxalate33$329
Trazodone Hcl34$312
Amlodipine Besylate56$311
Pantoprazole Sodium21$296
Duloxetine Hcl19$296
Glipizide ErGlipizide13$237

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$172$16,38114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 950 medical providers in Georgia.

Other medical in Suwanee

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →